Mitsubishi UFJ Asset Management Co. Ltd. Decreases Position in Revvity Inc. $RVTY

Mitsubishi UFJ Asset Management Co. Ltd. lessened its position in Revvity Inc. (NYSE:RVTY) by 42.2% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 138,866 shares of the company’s stock after selling 101,504 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd.’s holdings in Revvity were worth $13,630,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in the company. CYBER HORNET ETFs LLC bought a new stake in shares of Revvity during the second quarter valued at approximately $32,000. Cromwell Holdings LLC lifted its position in Revvity by 141.4% in the 4th quarter. Cromwell Holdings LLC now owns 338 shares of the company’s stock valued at $33,000 after acquiring an additional 198 shares in the last quarter. MUFG Securities EMEA plc purchased a new stake in Revvity during the 2nd quarter valued at $34,000. Headlands Technologies LLC purchased a new stake in Revvity during the 2nd quarter valued at $49,000. Finally, Smartleaf Asset Management LLC increased its holdings in shares of Revvity by 56.8% in the 3rd quarter. Smartleaf Asset Management LLC now owns 690 shares of the company’s stock worth $58,000 after purchasing an additional 250 shares in the last quarter. Hedge funds and other institutional investors own 86.65% of the company’s stock.

Revvity Stock Up 0.3%

Shares of RVTY stock opened at $101.32 on Monday. The company has a current ratio of 1.72, a quick ratio of 1.41 and a debt-to-equity ratio of 0.37. Revvity Inc. has a 12 month low of $81.22 and a 12 month high of $118.30. The stock has a market cap of $11.33 billion, a P/E ratio of 48.48, a P/E/G ratio of 2.18 and a beta of 1.05. The company has a 50 day simple moving average of $90.30 and a two-hundred day simple moving average of $96.90.

Revvity (NYSE:RVTY) last released its quarterly earnings results on Tuesday, May 5th. The company reported $1.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.02 by $0.04. The business had revenue of $711.12 million during the quarter, compared to analyst estimates of $704.07 million. Revvity had a return on equity of 8.00% and a net margin of 8.26%.Revvity’s revenue for the quarter was up 7.0% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.01 earnings per share. Revvity has set its FY 2026 guidance at 5.200-5.300 EPS. On average, research analysts expect that Revvity Inc. will post 5.33 earnings per share for the current year.

Revvity Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, August 7th. Stockholders of record on Friday, July 17th will be paid a $0.07 dividend. The ex-dividend date of this dividend is Friday, July 17th. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.3%. Revvity’s dividend payout ratio is 13.40%.

Analysts Set New Price Targets

RVTY has been the subject of several recent analyst reports. Barclays boosted their price target on Revvity from $95.00 to $105.00 and gave the stock an “equal weight” rating in a research note on Thursday. JPMorgan Chase & Co. reduced their price objective on Revvity from $96.00 to $90.00 and set a “neutral” rating for the company in a report on Wednesday, May 6th. Wells Fargo & Company boosted their target price on Revvity from $107.00 to $110.00 and gave the stock an “equal weight” rating in a research report on Tuesday, February 3rd. TD Cowen raised their price target on shares of Revvity from $115.00 to $120.00 and gave the company a “buy” rating in a report on Wednesday, May 6th. Finally, Jefferies Financial Group lifted their price target on shares of Revvity from $100.00 to $105.00 and gave the stock a “hold” rating in a research note on Monday, February 2nd. Four investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $107.73.

Revvity Company Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.